Establishment and characterization of somatic hybrids between human differentiated macrophages and mouse myeloma NS1 cells. 1990

A Bohbot, and A Faradji, and M Schmitt, and F Oberling, and F Uttwiller, and J V Ruch, and S Braun, and D Hartmann, and J Bartholeyns, and P Poindron
Institut d'Immunologie et d'Hématologie, Université Louis Pasteur, Strasbourg, France.

Human macrophages obtained from circulating monocytes matured in vitro by culture for seven days in hydrophobic flexible teflon bags were successfully fused with murine myeloma NS1 cells. Six of 20 clones, selected for their adherence properties, were further studied. All possessed human chromosomes (mean number ranging from 4 to 14 depending on the clones studied), exhibited non-specific esterases (but no peroxidase activity) and expressed CD14 antigen and C3 receptors (but no MAX-1 antigen). Moreover, the hybridomas retained phagocytic activity and high interferon plus lipopolysaccharide-activable cytolytic activity against tumor cells.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D009101 Multiple Myeloma A malignancy of mature PLASMA CELLS engaging in monoclonal immunoglobulin production. It is characterized by hyperglobulinemia, excess Bence-Jones proteins (free monoclonal IMMUNOGLOBULIN LIGHT CHAINS) in the urine, skeletal destruction, bone pain, and fractures. Other features include ANEMIA; HYPERCALCEMIA; and RENAL INSUFFICIENCY. Myeloma, Plasma-Cell,Kahler Disease,Myeloma, Multiple,Myeloma-Multiple,Myelomatosis,Plasma Cell Myeloma,Cell Myeloma, Plasma,Cell Myelomas, Plasma,Disease, Kahler,Multiple Myelomas,Myeloma Multiple,Myeloma, Plasma Cell,Myeloma-Multiples,Myelomas, Multiple,Myelomas, Plasma Cell,Myelomas, Plasma-Cell,Myelomatoses,Plasma Cell Myelomas,Plasma-Cell Myeloma,Plasma-Cell Myelomas
D010587 Phagocytosis The engulfing and degradation of microorganisms; other cells that are dead, dying, or pathogenic; and foreign particles by phagocytic cells (PHAGOCYTES). Phagocytoses
D011951 Receptors, Complement Molecules on the surface of some B-lymphocytes and macrophages, that recognize and combine with the C3b, C3d, C1q, and C4b components of complement. Complement Receptors,Complement Receptor,Complement Receptor Type 1,Receptor, Complement
D003601 Cytotoxicity Tests, Immunologic The demonstration of the cytotoxic effect on a target cell of a lymphocyte, a mediator released by a sensitized lymphocyte, an antibody, or complement. AHG-CDC Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Tests,Microcytotoxicity Tests,Anti Human Globulin Complement Dependent Cytotoxicity Tests,Anti-Human Globulin Complement-Dependent Cytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Test,Antiglobulin-Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunologic,Cytotoxicity Tests, Anti-Human Globulin Complement-Dependent,Cytotoxicity Tests, Immunological,Immunologic Cytotoxicity Test,Immunologic Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin-Augmented,Lymphocytotoxicity Tests, Antiglobulin-Augmented,Microcytotoxicity Test,AHG CDC Tests,AHG-CDC Test,Anti Human Globulin Complement Dependent Cytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Test,Antiglobulin Augmented Lymphocytotoxicity Tests,Cytotoxicity Test, Immunological,Cytotoxicity Tests, Anti Human Globulin Complement Dependent,Immunological Cytotoxicity Test,Immunological Cytotoxicity Tests,Lymphocytotoxicity Test, Antiglobulin Augmented,Lymphocytotoxicity Tests, Antiglobulin Augmented
D004950 Esterases Any member of the class of enzymes that catalyze the cleavage of an ester bond and result in the addition of water to the resulting molecules. Esterase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006825 Hybridomas Cells artificially created by fusion of activated lymphocytes with neoplastic cells. The resulting hybrid cells are cloned and produce pure MONOCLONAL ANTIBODIES or T-cell products, identical to those produced by the immunologically competent parent cell. Hybridoma

Related Publications

A Bohbot, and A Faradji, and M Schmitt, and F Oberling, and F Uttwiller, and J V Ruch, and S Braun, and D Hartmann, and J Bartholeyns, and P Poindron
February 1984, Journal of immunology (Baltimore, Md. : 1950),
A Bohbot, and A Faradji, and M Schmitt, and F Oberling, and F Uttwiller, and J V Ruch, and S Braun, and D Hartmann, and J Bartholeyns, and P Poindron
September 1976, Proceedings of the National Academy of Sciences of the United States of America,
A Bohbot, and A Faradji, and M Schmitt, and F Oberling, and F Uttwiller, and J V Ruch, and S Braun, and D Hartmann, and J Bartholeyns, and P Poindron
January 1983, Hybridoma,
A Bohbot, and A Faradji, and M Schmitt, and F Oberling, and F Uttwiller, and J V Ruch, and S Braun, and D Hartmann, and J Bartholeyns, and P Poindron
May 1981, Science (New York, N.Y.),
A Bohbot, and A Faradji, and M Schmitt, and F Oberling, and F Uttwiller, and J V Ruch, and S Braun, and D Hartmann, and J Bartholeyns, and P Poindron
May 1977, Somatic cell genetics,
A Bohbot, and A Faradji, and M Schmitt, and F Oberling, and F Uttwiller, and J V Ruch, and S Braun, and D Hartmann, and J Bartholeyns, and P Poindron
January 1983, Cytogenetics and cell genetics,
A Bohbot, and A Faradji, and M Schmitt, and F Oberling, and F Uttwiller, and J V Ruch, and S Braun, and D Hartmann, and J Bartholeyns, and P Poindron
August 1982, European journal of immunology,
A Bohbot, and A Faradji, and M Schmitt, and F Oberling, and F Uttwiller, and J V Ruch, and S Braun, and D Hartmann, and J Bartholeyns, and P Poindron
April 1968, Proceedings of the National Academy of Sciences of the United States of America,
A Bohbot, and A Faradji, and M Schmitt, and F Oberling, and F Uttwiller, and J V Ruch, and S Braun, and D Hartmann, and J Bartholeyns, and P Poindron
June 1978, International journal of cancer,
A Bohbot, and A Faradji, and M Schmitt, and F Oberling, and F Uttwiller, and J V Ruch, and S Braun, and D Hartmann, and J Bartholeyns, and P Poindron
July 1977, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!